|Home | About | Journals | Submit | Contact Us | Français|
Neospora caninum is an intracellular protozoan parasite that has drawn increasing interest due to its association with worldwide repetitive bovine abortions, which cause billionaire losses to the meat and dairy industries annually. Innate immunity plays an important role in infection control, and N. caninum activates the production of inflammatory mediators through toll-like receptors, NOD-like receptors, and mitogen-activated protein kinase signaling pathways. Advances in the knowledge of initial host–parasite interactions are desirable for the design of control measures against the infection, obliterating its pathogenesis. In that sense, we here aimed to describe the role of the innate C-type lectin receptor Dectin-1 during the infection by N. caninum. With that intent, we observed that the absence of Dectin-1, observed in genetically depleted (Dectin-1−/−) mice or competitively inhibited by an inert agonist [laminarin (LAM)], rescued 50% of the mice infected with lethal doses of N. caninum. Dectin-1−/− and LAM-treated mice also presented a reduction in the parasite load during acute and chronic phases, associated with decreased inflammatory scores in the central nervous system. Among all the cell phenotypes that migrated to the initial site of infection, dendritic cells and macrophages gained subpopulations with high Dectin-1 surface expression. The impairment of the receptor in these cells led to a decreased parasite burden, as well as augmented production of IL-12p40. We also found that Dectin-1+ cells produced less reactive oxygen species (ROS) at the initial site of the infection, while mice deficient in NADPH oxidase isoform 2 (NOX2−/−) were not able to control parasite replication and produce IL-12p40, even upon LAM treatment. Interestingly, the absence of functional Dectin-1 did not alter the susceptibility of mice against closely related Toxoplasma gondii. In conclusion, the gathered data suggest that Dectin-1 is involved in the parasite-induced downmodulation of ROS, and other key molecules triggered for the control of N. caninum infection and are a promising target for future development of protocols intended for intervention against neosporosis.
Apicomplexa parasites are important pathogens of animals and humans that cause diseases with widespread impact on global health (1). Neospora caninum and Toxoplasma gondii belong to this phylum. N. caninum was described initially as a causative agent of neurological diseases in dogs (2, 3). Currently, this protozoan is recognized worldwide as an important infectious cause of abortions in cows (4), generating significant losses to cattle raising farms aimed at milk and meat production (5), due to its highly efficient vertical transmission (6–8), whereas it seems to be apathogenic to humans (9, 10). T. gondii may cause illness in infected humans with a wide variety of clinical symptoms, as a mild, flu-like illness with low-grade fever, myalgia, malaise and headache, ranging to spontaneous abortions, mental and psychomotor retardation of newborns, retino-choroiditis, encephalitis, and hepatitis in adult individuals (11–13). Although phylogenetically related, these parasites show significant biological differences (14), as the reported distinctions in surface carbohydrate content, while N. caninum is highly glycosylated, T. gondii present low surface carbohydrate content (15).
According to in vivo and in vitro studies, protective immune responses against the infection by N. caninum are typically dependent of a Th1 profile, mediated by the production of proinflammatory cytokines IL-12p40 and IFN-γ, similar to that observed for T. gondii and other Apicomplexan parasites (16, 17). During the early stages of the infection, an appropriated innate immune response is mandatory for efficient parasite control, presenting hallmarks as antigenic recognition, presentation, and production of effector molecules as reactive oxygen species (ROS) and nitric oxide (NO). However, pathogens are eventually able to regulate the production of these molecules as an escape mechanism (18–20).
In different infectious processes, innate immune cells are able to directly recognize microbes through the interaction of pathogen-associated molecular patterns and pattern-recognition receptors (PRRs) (21–23). Due to this process, N. caninum and T. gondii are known to activate different PRRs during the infection, as toll-like receptor 2 (24), TLR3 (25), TLR4 (26), TLR11 (27), TLR12 (28, 29), as well as by cytosolic sensors as nucleotide-binding oligomerization domain containing 2 (30, 31), NOD-like receptor (NLR), NLR family pyrin domain containing 1 (NLRP1), and 3 (NLRP3) inflammasomes (32–34).
Dectin-1 is a C-type lectin, also known as CLEC7A, expressed by myeloid cells (dendritic cells, macrophages, and neutrophils), which specifically recognizes 1,3-β-glucan in a calcium-independent manner (35–37). After interaction between pathogens and Dectin-1, a transmembrane signaling promotes distinct cellular functions, as uptake and killing, production of cytokines, chemokines, and free radicals (38). Dectin-1 is associated with recognition of fungal antigens such as Candida albicans and Aspergillus fumigatus, as well as other pathogens such as Mycobacterium tuberculosis. However, the agonists derived from these pathogens are yet to be described (39–41).
Studies that demonstrate effective participation of this receptor in the immune response against protozoa are scarce in the literature. Evidence of the participation of Dectin-1 in infections by Leishmania infantum is still unclear, due to a dubious phenotype (42). Here, we demonstrate that Dectin-1 is related to evasion mechanisms triggered by N. caninum against the immune response mounted to protect the hosts, promoting the downregulation of IL-12p40 and effector molecules, consecutively compromising host resistance. On the other hand, Dectin-1 is not required for host’s resistance against closely related T. gondii.
All studies involving mice were approved by the animal research ethics committee at UFU (Comitê de Ética na Utilização de Animais da Universidade Federal de Uberlândia—CEUA/UFU), under protocol number 109/16. All procedures including housing and welfare were carried out in accordance with the recommendations in the Guiding Principles for Biomedical Research Involving Animals of the International Council for Laboratory Animal Science (ICLAS), countersigned by the Conselho Nacional de Controle de Experimentação Animal (CONCEA; Brazilian National Consul for the Control of Animal Experimentation) in its E-book (http://www.mct.gov.br/upd_blob/0238/238271.pdf). The UFU animal facility (Centro de Bioterismo e Experimentação Animal—CBEA/UFU) is accredited by the CONCEA (CIAEP: 01.0105.2014) and Comissão Técnica Nacional de Biossegurança (CTNBio, Brazilian National Commission on Biosecurity; CQB: 163/02).
For the experiments done in this work, we have used wild-type (WT) mice on a C57BL/6 background, along with genetically deficient littermates in Dectin-1 (Dectin-1−/−), and NADPH oxidase isoform 2 (NOX2−/−), with 6–8weeks old. All mice were bred and maintained at CBEA/UFU, in groups of maximum five animals inside each isolator cages, with light/dark cycle of 12h, food, and water ad libitum.
Neospora caninum tachyzoites (Nc-1 isolate) and T. gondii tachyzoites (RH, Pru, and Me49 strains) were maintained by continuous passages in a diploid-immortalized cell line derived from cervical cancer (HeLa; CCL-2, ATCC, Manassas, VA, USA). Briefly, HeLa cells were cultured in RPMI-1640 medium (Thermo Scientific Inc., Waltham MA, USA) supplemented with 25mM HEPES, 2mM l-glutamine, 100U/mL penicillin, 100μg/mL streptomycin, and 10% heat-inactivated calf fetal serum [fetal calf serum (FCS); Thermo Scientific] in an incubator under controlled temperature and atmosphere (37°C, 5% CO2, 95% relative humidity; Thermo Scientific). After HeLa infection with N. caninum, these cells were cultured in RPMI-1640 medium without FCS or, after infection with different strains of T. gondii, with 2% FCS. Extracellular parasites were washed twice (720×g, 10min, 4°C) with phosphate-buffered saline (PBS, 0.01M, pH 7.2), and the resulting pellet was resuspended in RPMI. Finally, the parasites were suspended in RPMI-1640 medium, and numbers of viable tachyzoites were determined by Trypan blue exclusion (Sigma-Aldrich, St. Louis, MO, USA) in a hemocytometer (43).
In order to obtain tissue cysts of the type II T. gondii Me49 strain, we maintained mice chronically infected with sub-lethal doses of the parasite. After 30–45days of infection, the brains were removed, homogenized, and washed in sterile PBS (pH 7.2) at 1,000×g for 10min. Tissue cysts were then counted under light microscopy for the experimental infection protocols. For in vivo assays involving survival and parasite burden, mice were infected through oral route (gavage) with 20 and 5 cysts, respectively (44, 45).
Bone marrow-derived macrophages were generated from bone marrow stem cells of WT and Dectin-1−/− mice, as previously described (46). Briefly, stem cells were cultured on 10cm-diameter polystyrene plates, for 7days in RPMI-1640 medium, containing HEPES 15mM, 2g of sodium bicarbonate/L, 1mM l-glutamine, supplemented with 20% heat-inactivated FCS and 30% cell-conditioned medium, obtained from the supernatant of confluent L929 cells (LCCM). Differentiated BMDMs were removed from the substrate by vigorous pipetting of ice-cold PBS. Cells were counted and used in the proportion of 1×106/mL for the experiments, in 96-well plates.
Bone marrow-derived dendritic cells (BMDCs) were generated as previously cited (24). Briefly, bone marrow stem cells were cultured on 10cm-diameter polystyrene plates in RPMI-1640 medium supplemented with 10% FCS and murine granulocyte-macrophage colony-stimulating factor (25ng/mL; BD Biosciences, San Jose, CA, USA). On day 3, supernatant was gently removed and replaced with the same volume of supplemented medium. On day 6, non-adherent cells were removed and placed in 96-well plates (1×106 cells/mL) prior to stimulation.
On the third day of infection, peritoneal cells from WT mice infected with 1×107 Nc-1 tachyzoites were collected and stained for phenotypic characterization and Dectin-1 expression. Briefly, mice were euthanized, and their peritoneal cavities were washed with ice-cold PBS. The suspension was then centrifuged at 400×g, at 4°C, for 10min. The cell pellet was resuspended in PBS with 5% of normal rabbit serum, at room temperature, for 15min, prior to incubation with the appropriate antibodies: anti-CD11b-APC-Cy7, anti-CD11c-FITC, anti-MHCII-PE, anti-CD11c-V450, anti-CD19-APC-Cy7, anti-CD3-Pacific Blue, anti-CD49b-APC (BD Biosciences), and anti-Dectin-1-PE (R&D Systems, Minneapolis, MN, USA). Cells were incubated with primary antibodies conjugated to the different fluorochromes for another 30min, at room temperature. After washing, cells were suspended in PBS with 3% formaldehyde, read by flow cytometry (FACSCantoII, BD Biosciences), and analyzed using dedicated software (FlowJo X, Tree Star Inc., Ashland, OR, USA).
Reactive oxygen species and NO production by peritoneal cells after 3days of infection were determined through fluorescent probes [CellROX Green Reagent (Thermo Scientific) and DAF-2 DA (Sigma-Aldrich), respectively], according to the manufacturers’ instructions. Briefly, peritoneal cells obtained from infected mice were incubated with each probe for 30min, at 37°C, followed by four washing cycles with PBS. The stained cell suspension was read by flow cytometry (FACSCantoII, BD Biosciences) and analyzed by dedicated software (FlowJo, Tree Star). Additionally, in vitro experiments were also undertaken, in order to determine ROS production in BMDMs generated from WT and Dectin-1−/− mice. Briefly, BMDMs (106 cells/mL) were infected with live Nc-1 tachyzoites (0.5:1, parasite:cell ratio) for 1h, at 37°C, 5% CO2, pretreated or not with laminarin (LAM) (500μg/mL) for 3h. After incubation, the supernatant was removed, and the cells were incubated with the probe for 30min, at 37°C, followed by six washing cycles with PBS. The reaction was read at a plate reader (M2e, Molecular Devices, Sunnyvale, CA, USA) under 488nm emission and 525nm excitation.
IL-12p40 production was analyzed in the peritoneal fluids and spleen homogenates of naïve and infected mice, as well as the supernatants harvested from cultured BMDCs and BMDMs. The samples were collected and immediately stored at −70°C until being assayed according to the manufactures’ instructions (Opteia set, BD Biosciences).
In vivo LAM (Sigma-Aldrich) treatment was performed during seven consecutive days. After the fourth day of treatment, mice were challenged with non-lethal (1×106) or lethal (1×107) doses of N. caninum tachyzoites, according to the aim of each assay. The dose of LAM used was 1mg/kg/day, by intraperitoneal route. For survival analysis, mice were followed twice a day, until the 30th day of infection, for clinical symptoms compatible with the infection. After advancement in morbidity scores and before the occurrence of natural death induced by the experimental challenge, mice were euthanized to avoid excessive suffering.
For acute parasitism analysis, we stained the parasites with fluorescent reactive ester dyes, to allow the identification of parasite-associated cells as previously described (43). Briefly, approximately 3×107 tachyzoites/mL was pre-stained with CFDA-SE (5μM/mL; CFSE; Thermo Scientific). After 10min at 37°C, the tachyzoites were washed with 10mL of RPMI-1640 with 10% FCS and centrifuged at 800×g, for 10min, at 4°C. Viable tachyzoites were determined with the Trypan blue exclusion test and used to infect mice, BMDCs and BMDMs. For in vivo assays, mice were intraperitonally infected with 1×107 CFSE+ Nc-1 tachyzoites, and the peritoneal cells were extracted on the third day of infection for analysis of CFSE-associated cells gated within the monocyte region, determined by gating under FSC-A and SSC-A parameters. In vitro, BMDMs were infected with CFSE+ Nc-1 tachyzoites (MOI 1) and analyzed after 24h of infection. The parasitism was given as percent or intensity of CFSE+ cells after being read in a flow cytometer (FACSCantoII, BD) and analyzed by dedicated software (FlowJo, Tree Star).
Chronic parasitism was determined in brain tissue from mice after 30days of infection with N. caninum or T. gondii by real-time quantitative polymerase chain reaction as described elsewhere (47). Primer pairs designed for the Nc-5 region (Np6/Np21) of N. caninum (sense: 3′-GCTGAACACCGTATGTCGTAAA-5′; antisense: 3′-AGAGGAATGCCACATAGAAGC-5′) and T. gondii’s B1 gene (sense: 3′-GCTCCTCCAGCCGTCTTG-5′; antisense: 3′-TCCTCACCCTCGCCTTCAT) were used in assays based on SYBR green detection system (Promega Co., Madison, WI, USA). DNA extraction was performed from 20mg of murine brain tissues using a commercial kit (Wizard SV Genomic DNA kit, Promega) according to the manufacturer’s instructions. DNA concentrations were determined by UV spectrophotometry (260nm; Nanodrop Lite, Thermo Scientific) and adjusted to 200ng/μL with sterile DNAse free water. Assays to determine N. caninum and T. gondii parasite loads were performed through real-time PCR (StepOnePlus, Thermo Scientific) and calculated by interpolation from a standard curve with DNA equivalents extracted from tachyzoites included in each run. Brain tissue from naïve mice was analyzed in parallel as negative control.
Brain tissue sections obtained from mice after 30days of infection were stained with hematoxylin and eosin and examined by light microscopy to detect tissue damage. Inflammatory scores were represented as arbitrary units: 0–1, mild; 1–2, moderate; 2–3, severe; and >3, very severe; according to previously described protocol (48). Brain tissue samples from naïve mice served as negative controls.
Statistical significance of the results was checked using non-parametric one-way analysis of variance followed by Bonferroni’s post hoc test (for three or more groups) comparing all pairs of columns, or two-tailed Student’s t-test (for two groups). Differences in survival rates between groups were compared using Kaplan–Meier survival analysis, through a log-rank Mantel–Cox test. In all measurements, a p value <0.05 was deemed as statistically significant. Analysis was performed with the aid of commercial software (GraphPad Prism, San Diego, CA, USA).
Dectin-1 is an innate receptor related until now with β-glucan recognition. Its role as a PRR has been described in infections by fungal, bacteria, and some protozoa. With that intent, our initial goal was to evaluate the role of this receptor in mice survival and parasite burden during lethal infection protocol (DL100) with N. caninum tachyzoites. Dectin-1−/− mice were more resistant to infection (p=0.0090), since 50% of the genetically deficient mice survived the DL100 challenge (Figure (Figure1A).1A). Our next step was to evaluate if Dectin-1 also interfered with the acute and chronic parasitism, during a non-lethal infection protocol. Dectin-1−/− mice presented a decreased number of parasitized (CFSE+) cells in the peritoneal cavity during the acute phase (p<0.01, Figure Figure1B),1B), and lower concentration of parasite genomic DNA during chronic infections (p=0.0002, Figure Figure1C),1C), demonstrating that the presence of functional Dectin-1 contributes to the susceptibility of mice to the infection by N. caninum.
Since Dectin-1−/− mice presented increased resistance to N. caninum, our next step was to evaluate if the expression of the receptor was altered during the acute phase of the infection. For that purpose, WT mice were infected with non-lethal doses of N. caninum tachyzoites and evaluated for Dectin-1 expression in different phenotypes of peritoneal cells after 3days of infection. The most pronounced differences in Dectin-1 expression were observed in antigen-presenting cells (dendritic cells and macrophages), which are the primary inducers of appropriated adaptive immune responses. Resident dendritic cells (CD11b+CD11c+ cells, gated in the monocyte region) in the peritoneal cavity of naïve mice showed constitutive expression of Dectin-1 in its surface (Dectin-1+ DCs=97.6%). However, during acute infection, two distinct populations were clearly observed (CD11b+CD11c+Dectin-1− and CD11b+CD11c+Dectin-1+), where the expression of Dectin-1 in positive cells was considerably increased (Figure (Figure2A).2A). The same pattern of events was observed for macrophages (CD11b+CD11c− cells, gated in the monocyte region). While a homogenous constitutive expression of the receptor was observed in resident cells obtained from naïve mice, macrophages obtained during acute infection showed polarized cell phenotypes: an increased proportion of Dectin-1− macrophages versus Dectin-1+ cells with high expression of the receptor (Figure (Figure2A).2A). No relevant differences in Dectin-1 expression were observed in polymorphonuclear cells and lymphocytes (NK, T, and B; data not shown).
Given the differences observed in Dectin-1 expression induced by the infection in antigen-presenting cells, our next question was if the presence of the functional receptor altered IL-12p40 production, an important proinflammatory mediator related to the control of parasite replication during the acute phase of the infection. With that intent, WT and Dectin-1−/− mice were infected with non-lethal doses of N. caninum tachyzoites for the assessment of IL-12p40 production after 3days of infection. Our results showed increased levels of this cytokines in the peritoneal fluid (p<0.001, Figure Figure2B)2B) and spleen homogenates (p<0.001, Figure Figure2C),2C), when compared to WT mice.
Due to the previous observations, and taken that antigen-presenting cells are crucial for the induction of proper Th1-biased immune responses against N. caninum, we then aimed to evaluate whether Dectin-1 would directly affect the ability of dendritic cells and macrophages to increase the production of IL-12p40, a crucial molecule during antigen presentation in N. caninum infection. For that, we undertook experiments, which exposed BMDCs and BMDMs, obtained from WT and Dectin-1−/− mice, to live N. caninum tachyzoites in vitro. In that context, we observed that Dectin-1−/− BMDC (Figure (Figure2D)2D) and BMDM (Figure (Figure2E)2E) presented augmented production of IL-12p40 (p<0.001), compared to WT cells after incubation with N. caninum live tachyzoites for 24h.
Taken together, these data suggest that N. caninum tampers with Dectin-1 expression in antigen-presenting cells, negatively regulating the production of crucial molecules for the mounting of effective immune responses against the infection.
Once we observed that the absence of Dectin-1 is associated with increased resistance of the host against N. caninum infection, due to an increment of IL-12p40 linked to the infection control, we next aimed to assess whether the use of LAM, a competitive inhibitor of Dectin-1, would be suitable to be employed in therapeutic measures against the parasite. Treatment with LAM rescued 50% of the challenged animals with DL100 (p=0.0415), similar to the result obtained using Dectin-1−/− mice (Figure (Figure3A).3A). In addition, after 3days of infection, mice challenged with N. caninum and treated with LAM presented increased levels of IL-12p40 in the peritoneal fluid (p=0.0159, Figure Figure3B)3B) associated with decreased parasitism in peritoneal monocytic cells (p=0.0110, Figure Figure3C)3C) during the acute phase of a non-lethal infection protocol. During the chronic phase of the infection, this phenotype of increased resistance was maintained in mice treated with LAM, which presented a reduced concentration of parasite genomic DNA in the central nervous system (p=0.0097, Figure Figure3D),3D), associated with a decreased inflammatory score (p=0.0095, Figure Figure33E).
Based on these findings, we next sought to shed some light into the molecular mechanism rendering protection against N. caninum infection, upon blockage of Dectin-1. During infections, it is well described that different effector molecules are related to the elimination of intracellular pathogens, with ROS and NO as hallmarks of this process (38, 49–52). Thus, we evaluated if LAM treatment interfered with the production of these free radicals during in vivo experiments with non-lethal infections with live tachyzoites. We observed that LAM significantly increased ROS expression in monocytic peritoneal cells (p=0.0273) but maintained stable percentage of NO+ cells after 3days of infection (Figure (Figure4A).4A). We further confirmed this phenomenon with an in vitro experiment (Figure (Figure4B),4B), where we demonstrate that the treatment of WT BMDMs with LAM does significantly increase ROS production (p=0.008) during infection with live tachyzoites, similar to the levels produced by Dectin-1−/− BMDMs. On the other hand, and as expected, LAM did not produce an additive effect in ROS produced by Dectin-1−/− BMDMs (p=0.751). To evaluate if ROS, which has not yet been described during N. caninum infection, is related to parasite control, we used WT and genetically deficient mice in NOX2−/− to evaluate their ability to control acute parasite replication using CFSE-stained parasites. As expected, we observed that NOX2−/− mice failed to control parasite replication due to the increased expression of CFSE detected in the peritoneal cells gated in the monocyte region (Figure (Figure4C),4C), demonstrating that ROS is critical for the control of N. caninum replication.
To elucidate whether LAM would be able to control parasite replication in a ROS-independent manner, which would indicate that the molecular mechanism behind protection upon Dectin-1 blockage would be performed by distinct molecules, WT and NOX2−/− mice were treated with LAM and infected to evaluate the monocytic peritoneal parasitism with CFSE+ tachyzoites. Interestingly, while LAM-treated WT mice presented a decreased peritoneal monocytic parasite burden; the intensity of CFSE+ cells in the peritoneal cavity of NOX2−/− remained practically unaltered upon treatment (Figure (Figure4D).4D). Finally, we aimed to correlate if Dectin-1 mediated inhibition of ROS production during N. caninum infection would also affect IL-12p40 production in the infected mice. For that, WT and NOX2−/− mice were treated with LAM and infected for 3days for cytokine measurement in the peritoneal fluid. As already demonstrated, WT mice produced IL-12p40 upon infection, which was significantly increased in LAM-treated mice (p=0.0188). Surprisingly, NOX2−/− mice were not able to respond to the infectious stimulus with the production of the referred cytokine, which was not even partially reverted by LAM (Figure (Figure44E).
In that context, our results suggest that LAM treatment is efficient to control the pathogenesis of the infection in the proposed models, through a mechanism regulated by the increase in ROS production and consequent upregulation of IL-12p40 during the acute phase of the infection.
Although closely related, N. caninum and T. gondii present marked biological distinctions, as its surface carbohydrate contents (15). We then aimed to answer whether the absence of Dectin-1 would protect mice against T. gondii infection, in the same fashion as seen for N. caninum. For this, a set of in vivo experiments using different clonal T. gondii strains, doses and routes of infection were carried out in WT and Dectin-1−/− mice. Overall, no differences were noted in susceptibility/resistance of the animals submitted to the infectious protocols.
Initially, survival assays were undertaken. WT and Dectin-1−/− mice infected by intraperitoneal route with 1×102 tachyzoites of RH strain (type I) succumbed, in a similar fashion, to the challenge, with 100% lethality of the different groups until the 10th day postinfection (Figure (Figure5A).5A). Dectin-1−/− mice were also checked for increased survival against type II strains. WT and Dectin-1 mice were challenged with Pru strain tachyzoites (1×104), by intraperitoneal route, with full lethality being observed in both groups after 7days of infection (Figure (Figure55B).
We also evaluated if the infection protocol was affecting the experimental observations. For that, we adopted Me49 strain (type II) to test distinct infectious doses and routes. WT and Dectin-1−/− mice were then infected with 1×103 or 1×105 tachyzoites, by intraperitoneal route, and both groups showed similar survival curves, with all animals succumbing to the infection until the 12th day (Figures (Figures5C,D).5C,D). To evaluate whether the route of the infection would induce differential resistance mediated by Dectin-1, WT and Dectin-1−/− mice were infected by the oral route, with 30 cysts of Me49 strain for survival analysis, or 5 cysts for the evaluation of chronic parasitism in the brain. Once more, our results did not point out differences in survival rates among the groups (Figure (Figure5E),5E), nor in chronic phase parasitism (Figure (Figure55F).
Thus, unlike of the observed for N. caninum, these sets of in vivo experiments with T. gondii demonstrate that Dectin-1 is differentially regulated in infections caused by the two closely related parasites.
During infections by protozoans, the activation of innate immune responses is critical for the development of effective immune response, which culminates in the restriction of microbial multiplication (25). N. caninum is an important veterinary pathogen that induces reproductive loses in cattle, as well as neurologic diseases in dogs (5). Given the importance of this parasite, our group has been dedicated in the last years to understand the mechanisms related to immunity against this parasite, especially regarding innate sensors. We have previously demonstrated that toll-like receptors (TLRs) are essential for host resistance against neosporosis, since MyD88 and TLR2 ablation produced pronounced effects over the development of a specific Th1 response, based on the classical IL-12/IFN-γ axis, during the course of infection (24, 53); other classes of receptors—as Nod2—are also relevant in the pathogenesis of the disease (30).
Dectin-1 is a well-characterized β-glucan receptor specially related to fungal recognition. Nevertheless, increasing number of reports suggests that it also has relevant functions during infection by other pathogenic agents, such as bacteria and protozoan. In this work, our major aim was to show that Dectin-1 plays an important role in downmodulating the immune response against N. caninum, but not for the phylogenetic-related parasite T. gondii. We show that the absence of Dectin-1 rescues mice challenged with lethal doses of N. caninum tachyzoites, but no differences were observed in the survival rate of mice infected with distinct stains, routes, or doses of T. gondii.
In fact, the role of each PRR is strictly related to the pathogen. This phenomenon has been evidenced in studies with fungi, where simple modifications in antigenic complexes between different strains of C. albicans induce significant changes in survival rates in Dectin-1−/− mice (54). To our knowledge, there are no known agonist of Dectin-1 described in N. caninum and T. gondii. However, the differences in survival and parasite burden obtained for both parasites in our experimental model may be related to the antigenic composition of each parasite, more specifically, the glycosylation and carbohydrate content of surface proteins (15). In order for the host to have greater resistance during the infectious processes, the control of parasite replication is crucial (55). Thus, we associated the higher survival rates observed in Dectin-1−/− mice with their larger ability to control N. caninum replication in both acute and chronic stages of infection, fact not observed in T. gondii infection.
Dectin-1 is predominantly expressed on the surface of myeloid cells as monocyte/macrophages and neutrophil lineages (56). Here, we observed Dectin-1 expression in different cell phenotypes, at the initial site of infection during the acute phase. As expected, no differences in Dectin-1 expression were observed in lymphoid cells, but N. caninum infection induced changes in Dectin-1 expression in populations of dendritic cells and macrophages. We found a decrease in the percentage of cells expressing Dectin-1 after the infection, which changed from homogeneous positive populations to a dichotomy of receptor negative cells and ones with high expression of the PRR. In association, WT (Dectin-1+) mice presented dendritic cells and macrophages with reduced IL-12p40 production after contact with live tachyzoites, which by its turn is followed by an increased parasite burden in both acute and chronic phases of infection. An effective control of infections by intracellular pathogens is closely linked to an innate immune response that culminates in the activation of an adaptive response, capable of neutralizing forms of the parasite disseminated through the blood stream and lymphatic system (57, 58). With that intent, antigen presentation assumes a central role in the activation of effective adaptive immune responses (59). Altogether, these data demonstrate that there is a direct or indirect interaction between N. caninum and Dectin-1, which compromises the effectiveness of the immune response triggered against the parasite.
Using this rationale, Dectin-1 blockade would be desirable as a potential therapeutic strategy against neosporosis. In this scenario, we suggest that LAM may be tested in the treatment against this infection, once it interacts directly with Dectin-1, is inert, is efficient as we show here and, among the β-1,3-glucans, the compound obtained from Laminaria digitata has high solubility in water and presents low polydispersity, characteristics that makes this compound desirable to the pharmaceutical industry (60, 61).
Reactive oxygen species are generated through the activation of diverse signaling pathways, including Dectin-1 and TLR-induced innate immune responses, promoting antimicrobial activity and local inflammation (38, 62–64). It has already been demonstrated that NADPH oxidase-derived ROS plays an essential role in inflammatory responses and anti-parasitic activity against T. gondii (62, 64). Additionally, excreted-secreted antigens from T. gondii or cell membrane stress due to the parasites’ active invasion mechanism and lytic cycle are efficient in ROS induction (50, 52). However, ROS formation and its consequences in response to N. caninum infection had yet to be determined. For the first time, we present here that ROS is important in the control of N. caninum replication, since the parasite load in NOX2−/− mice was uncontrolled. We have also shown that Dectin-1 is a negative regulator of ROS during the infection, since competitive inhibition of the receptor specifically increased ROS production by peritoneal cells, while it did not interfere with NO synthesis (65, 66). Furthermore, we show that Dectin-1 downmodulation of ROS hampers its ability to act as a positive regulator of Th1 immune responses, favoring IL-12p40 production and consequent proinflammatory molecules required for parasite restriction (24, 67).
Altogether, the data herein gathered demonstrate that N. caninum evades effector immune responses through Dectin-1-mediated dampening of ROS and, consequently, Th1 pathways. We also show that an inert receptor agonist may be used to control the pathogenesis of the infection in mice, which should be transposed for infection models using dogs and cattle—species directly affected by N. caninum—in an attempt to reduce abortions and deaths caused by neosporosis.
Conceived and designed the experiments: MS, FS, JM, and TM; performed the experiments: MS, FF, CM, FS, AJ, and ER; analyzed the data and wrote the paper: MS, JM, and TM; supplied reagents: JM and TM.
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The authors thank Marley Dantas Barbosa, Zilda Mendonça da Silva, and Ana Claúdia Marquez Pajuaba for their technical assistance, Prof. Carlos Henrique Serenzani (Vanderbilt University, USA) for initial advices on the model and for a-Dectin-1 MAb, Prof. Gordon D. Brown (University of Aberdeen, Scotland) and Prof. Vera Lucia Garcia Calich (Universidade de São Paulo, Brazil) for the Dectin-1−/− mice, Prof. Leda Quercia Vieira (Universidade Federal de Minas Gerais, Brazil) and Prof. Marcelo José Barbosa Silva (Universidade Federal de Uberlândia, Brazil) for NOX2−/− mice, and Prof. João Santana da Silva (Faculdade de Medicina de Ribeirao Preto—USP) for reagents and mice.
This work was supported by the following Brazilian research funding agencies: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, 309011/2013-2), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES, AUX-PE-Parasitologia-1348/2011), and Fundação de Amparo a Pesquisa de Minas Gerais (FAPEMIG, CDS-RED-00013-14, CVZ-PPM-00784-15, CVZ-APQ-01313-14, CDS-PPM-00162-16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.